Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Paul Jorgensen

Paul Jorgensen

ID: 1b839954-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

PMPRB opens consultation to streamline Board hearings

Pharma in Brief · March 9, 2026

Health Canada proposes expediting drug approvals by relying on foreign regulatory decisions

Pharma in Brief · February 5, 2026

Health Canada Announces Long-Awaited Clinical Trial Regulations

Pharma in Brief · January 26, 2026

Pharma in Brief’s 2025 Year in Review and What to Watch for in 2026

Pharma in Brief · January 19, 2026

Agile drug licensing: Health Canada consulting on new “terms and conditions” guidance to replace its Notice of Compliance with Conditions policy

Pharma in Brief · January 7, 2026

Previous

12...11

Next

Practice Areas

Health Care and Life Sciences

Jurisdictions

Publishing Record

Publisher Since 2018

Total Articles 55

Most Recent March 9, 2026

Cite This Author

Paul Jorgensen, Norton Rose Fulbright

LexBlog Author ID:

1b839954-2619-30fb-68c4

www.lexblog.com/author/pauljorgensen

Contact

FirmNorton Rose Fulbright

Emailpaul.jorgensen@nortonrosefulbright.com

BlogPharma in Brief

LinkedInView Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog